Neurodevelopmental Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2024-01-12
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2024
PRAC highlights potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines and recommends preca…